Omaha, NE, United States of America

Robert A Goodnow

This inventor holds 8 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Schering Corporation, Chromalloy American Corporation, Iowa State University Research Foundation Inc.. Active years: 1979-1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert A Goodnow. Retrieved from https://idiyas.com/inventor/robert-a-goodnow

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.6

ph-index = 7

Forward Citations = 126(Granted Patents)


Company Filing History:


Years Active: 1979-1985

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Robert A. Goodnow

Introduction: Robert A. Goodnow is an inventor based in Concord, MA (US). He is currently associated with Xrad Therapeutics, Inc. Although he has not yet been granted any patents, his work focuses on significant advancements in the field of oncology. Goodnow collaborates with notable colleagues, including Jianmin Fu and Yaode Wang, to develop innovative therapeutic solutions.

Latest Patent Applications: One of Goodnow's recent patent applications is titled "Dual ATM and DNA-PK Inhibitors for Use in Anti-Tumor Therapy." This application presents compounds of formula (I) and their pharmaceutically acceptable salts. The described compounds and their pharmaceutical compositions may be beneficial in treating oncologic diseases.

Conclusion: Robert A. Goodnow is making strides in the field of cancer therapy through his innovative research and collaborative efforts. His contributions, although not yet reflected in granted patents, hold promise for future advancements in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…